FDA Advisory Committee: Lutonix comes away with win at advisory for drug-coated balloon June 16, 2014 By Mark McCarty
TAVR/TAVI Takes Center Stage: Shift toward lower-risk patient pools seen as key growth driver for TAVR June 16, 2014 By Amanda Pedersen The topic of the transcatheter valve replacement (TAVR) market, also known as transcatheter valve implantation (TAVI), brings to mind the classic Dr. Seuss story, "Oh, the Places You'll Go."Read More
RSS